These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 32648508)

  • 41. Left ventricular dimension decrement index early after axial flow assist device implantation: A novel risk marker for late pump thrombosis.
    Joyce E; Stewart GC; Hickey M; Coakley L; Rivero JM; Gosev I; Givertz MM; Couper GS; Mehra MR
    J Heart Lung Transplant; 2015 Dec; 34(12):1561-9. PubMed ID: 26508725
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Gender Differences in Outcomes After Implantation of Left Ventricular Assist Devices.
    Ahmed A; Adegbala O; Akintoye E; Inampudi C; Ajam M; Yassin AS; Olawusi E; Shokr M; Alvarez P; Briasoulis A
    Ann Thorac Surg; 2020 Mar; 109(3):780-786. PubMed ID: 31479642
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables.
    John R; Pagani FD; Naka Y; Boyle A; Conte JV; Russell SD; Klodell CT; Milano CA; Rogers J; Farrar DJ; Frazier OH
    J Thorac Cardiovasc Surg; 2010 Jul; 140(1):174-81. PubMed ID: 20447659
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Assessing in-hospital cardiovascular, thrombotic and bleeding outcomes in patients with chronic liver disease undergoing left ventricular assist device implantation.
    Grant JK; Ebner B; Vincent L; Maning J; Olorunfemi O; Olarte NI; Colombo R; Munagala M; Chaparro S
    Thromb Res; 2021 Jun; 202():184-190. PubMed ID: 33892219
    [TBL] [Abstract][Full Text] [Related]  

  • 45. How does age affect outcomes after left ventricular assist device implantation: results from the PCHF-VAD registry.
    Radhoe SP; Veenis JF; Jakus N; Timmermans P; Pouleur AC; Rubís P; Van Craenenbroeck EM; Gaizauskas E; Barge-Caballero E; Paolillo S; Grundmann S; D'Amario D; Braun OÖ; Gkouziouta A; Planinc I; Samardzic J; Meyns B; Droogne W; Wierzbicki K; Holcman K; Flammer AJ; Gasparovic H; Biocina B; Lund LH; Milicic D; Ruschitzka F; Cikes M; Brugts JJ
    ESC Heart Fail; 2023 Apr; 10(2):884-894. PubMed ID: 36460627
    [TBL] [Abstract][Full Text] [Related]  

  • 46. An 18-month comparison of clinical outcomes between continuous-flow left ventricular assist devices.
    Itzhaki Ben Zadok O; Ben-Avraham B; Shaul A; Hammer Y; Rubachevski V; Aravot D; Kornowski R; Ben-Gal T
    Eur J Cardiothorac Surg; 2019 Dec; 56(6):1054-1061. PubMed ID: 31566245
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Low incidence of gastrointestinal bleeding and pump thrombosis in patients receiving the INCOR LVAD system in the long-term follow-up.
    Iacovoni A; Centofanti P; Attisani M; Verde A; Terzi A; Senni M; Maiani M; Baronetto A; Livi U; Frigerio M; Rinaldi M
    Int J Artif Organs; 2015 Oct; 38(10):542-7. PubMed ID: 26541278
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Sildenafil Is Associated With Reduced Device Thrombosis and Ischemic Stroke Despite Low-Level Hemolysis on Heart Mate II Support.
    Saeed O; Rangasamy S; Selevany I; Madan S; Fertel J; Eisenberg R; Aljoudi M; Patel SR; Shin J; Sims DB; Reyes Gil M; Goldstein DJ; Slepian MJ; Billett HH; Jorde UP
    Circ Heart Fail; 2017 Nov; 10(11):. PubMed ID: 29092891
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Predictors of the response to phosphodiesterase-5 inhibitors in pulmonary arterial hypertension: an analysis of the Spanish registry.
    Garcia AR; Blanco I; Ramon L; Pérez-Sagredo J; Guerra-Ramos FJ; Martín-Ontiyuelo C; Tura-Ceide O; Pastor-Pérez F; Escribano-Subías P; Barberà JA
    Respir Res; 2023 Sep; 24(1):223. PubMed ID: 37715261
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Identifying Temporal Relationships Between In-Hospital Adverse Events After Implantation of Durable Left Ventricular Assist Devices.
    Kilic A; Seese L; Pagani F; Kormos R
    J Am Heart Assoc; 2020 Apr; 9(8):e015449. PubMed ID: 32285751
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy.
    John R; Kamdar F; Liao K; Colvin-Adams M; Boyle A; Joyce L
    Ann Thorac Surg; 2008 Oct; 86(4):1227-34; discussion 1234-5. PubMed ID: 18805167
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Medication management for left ventricular assist device thrombosis.
    Hohner E; Crow J; Moranville MP
    Am J Health Syst Pharm; 2015 Jul; 72(13):1104-13. PubMed ID: 26092961
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Outcomes After Continuous-Flow Left Ventricular Assist Device Implantation as Destination Therapy at Transplant Versus Nontransplant Centers.
    Brinkley DM; DeNofrio D; Ruthazer R; Vest AR; Kapur NK; Couper GS; Kiernan MS
    Circ Heart Fail; 2018 Mar; 11(3):e004384. PubMed ID: 29540471
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Impact of time off anticoagulation in patients with continuous-flow left ventricular assist devices.
    Inchaustegui CA; Patel A; Lamba HK; Brown A; Arunthamakun J; Ting K; Chatterjee S; Nair AP; George JK; Shafii AE; Liao KK; Civitello AB
    J Artif Organs; 2023 Dec; 26(4):275-286. PubMed ID: 36208373
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The Society of Thoracic Surgeons Intermacs Database Annual Report: Evolving Indications, Outcomes, and Scientific Partnerships.
    Kormos RL; Cowger J; Pagani FD; Teuteberg JJ; Goldstein DJ; Jacobs JP; Higgins RS; Stevenson LW; Stehlik J; Atluri P; Grady KL; Kirklin JK
    Ann Thorac Surg; 2019 Feb; 107(2):341-353. PubMed ID: 30691584
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Thromboembolic stroke in patients with a HeartMate-II left ventricular assist device - the role of anticoagulation.
    van den Bergh WM; Lansink-Hartgring AO; van Duijn AL; Engström AE; Lahpor JR; Slooter AJ
    J Cardiothorac Surg; 2015 Oct; 10():128. PubMed ID: 26471178
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Current results of left ventricular assist device therapy in France: the ASSIST-ICD registry.
    Anselmi A; Galand V; Vincentelli A; Boule S; Dambrin C; Delmas C; Barandon L; Pernot M; Kindo M; Tam HM; Gaudard P; Rouviere P; Senage T; Michel M; Boignard A; Chavanon O; Verdonk C; Para M; Gariboldi V; Pelce E; Pozzi M; Obadia JF; Anselme F; Litzler PY; Babatasi G; Belin A; Garnier F; Bielefeld M; Guihaire J; Kloeckner M; Radu C; Lellouche N; Bourguignon T; Genet T; D'Ostrevy N; Duband B; Jouan J; Bories MC; Vanhuyse F; Blangy H; Colas F; Verhoye JP; Martins R; Flecher E
    Eur J Cardiothorac Surg; 2020 Jul; 58(1):112-120. PubMed ID: 32298439
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evaluation of anticoagulation and nonsurgical major bleeding in recipients of continuous-flow left ventricular assist devices.
    Veasey TM; Floroff CK; Strout SE; McElray KL; Brisco-Bacik MA; Cook JL; Toole JM; Craig ML; Van Bakel AB; Meadows HB; Uber WE
    Artif Organs; 2019 Aug; 43(8):736-744. PubMed ID: 30868618
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Implantable Cardioverter Defibrillators in Patients With Continuous Flow Left Ventricular Assist Devices: Utilization Patterns, Related Procedures, and Complications.
    Alvarez PA; Sperry BW; Pérez AL; Yaranov DM; Randhawa V; Luthman J; Cantillon DJ; Starling RC
    J Am Heart Assoc; 2019 Jul; 8(14):e011813. PubMed ID: 31280637
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Increased bleeding risk with phosphodiesterase-5 inhibitors after left ventricular assist device implantation.
    Jakstaite AM; Luedike P; Schmack B; Pizanis N; Riebisch M; Weymann A; Kamler M; Ruhparwar A; Rassaf T; Papathanasiou M
    ESC Heart Fail; 2021 Aug; 8(4):2419-2427. PubMed ID: 33821578
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.